REAL-WORLD DOSING PATTERNS OF ECULIZUMAB-NAIVE AND ECULIZUMAB-EXPERIENCED PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA RECEIVING RAVULIZUMAB IN THE US

被引:0
|
作者
Cheng, W. Y. [1 ]
Fishman, J. [2 ]
Yenikomshian, M. [1 ]
Mahendran, M. [1 ]
Kunzweiler, C. [1 ]
Vu, J. D. [1 ]
Duh, M. S. [1 ]
机构
[1] Anal Grp Inc, Boston, MA USA
[2] Apellis Pharmaceut Inc, Waltham, MA USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
HSD77
引用
收藏
页码:S493 / S493
页数:1
相关论文
共 50 条
  • [1] Real-World Eculizumab Dosing Patterns Among Patients with Paroxysmal Nocturnal Hemoglobinuria in a US Population
    Cheng, Wendy Y.
    Sarda, Sujata P.
    Mody-Patel, Nikita
    Krishnan, Sangeeta
    Yenikomshian, Mihran
    Kunzweiler, Colin
    Vu, Jensen Duy
    Cheung, Hoi Ching
    Duh, Mei Sheng
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2022, 14 : 357 - 369
  • [2] Real-World Eculizumab Dosing Patterns Among Patients with Paroxysmal Nocturnal Hemoglobinuria in a US Population
    Cheng, Wendy Y.
    Sarda, Sujata P.
    Mody-Patel, Nikita
    Krishnan, Sangeeta
    Yenikomshian, Mihran
    Scoble, Patrick J.
    Kunzweiler, Colin
    Vu, Jensen Duy
    Cheung, Hoi Ching
    Duh, Mei Sheng
    [J]. BLOOD, 2020, 136
  • [3] REAL-WORLD EFFECTIVENESS OF ECULIZUMAB, SWITCH TO RAVULIZUMAB AND RAVULIZUMAB AS FIRST THERAPY IN SWISS PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
    Rovo, A.
    Simeon, L.
    Gavillet, M.
    Samii, K.
    Cantoni, N.
    Drexler, B.
    Stussi, G.
    Bissig, M.
    [J]. SWISS MEDICAL WEEKLY, 2023, 153 : 30S - 31S
  • [4] Real-World Ravulizumab Dosing Patterns Among Patients with Paroxysmal Nocturnal Hemoglobinuria in a US Population
    Cheng, Wendy Y.
    Fishman, Jesse
    Sarda, Sujata P.
    Krishnan, Sangeeta
    Kunzweiler, Colin
    Vu, Jensen Duy
    Yenikomshian, Mihran
    Duh, Mei Sheng
    [J]. BLOOD, 2021, 138
  • [5] Real-World Efficacy of Eculizumab for Paroxysmal Nocturnal Hemoglobinuria in South Korea: Paradox of Eculizumab
    Kang, Ka-Won
    Moon, Hyemi
    Lee, Byung-Hyun
    Jeon, Min Ji
    Yu, Eun Sang
    Kim, Dae Sik
    Lee, Se Ryeon
    Sung, Hwa Jung
    Kim, Seok Jin
    Choi, Chul Won
    Kim, Byung Soo
    Lee, Juneyoung
    Park, Yong
    [J]. BLOOD, 2019, 134
  • [6] Real-World Treatment Patterns and Healthcare Resource Utilization (HRU) of Patients (Pts) with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population
    Cheng, Wendy Y.
    Sarda, Sujata P.
    Mody-Patel, Nikita
    Krishnan, Sangeeta
    Yenikomshian, Mihran
    Scoble, Patrick J.
    Mahendran, Malena
    Lejeune, Dominique
    Yu, Louise
    Duh, Mei Sheng
    [J]. BLOOD, 2020, 136
  • [7] Cost burden of breakthrough hemolysis in patients with paroxysmal nocturnal hemoglobinuria receiving ravulizumab versus eculizumab
    Tomazos, Ioannis
    Sierra, J. Rafael
    Johnston, Karissa M.
    Cheung, Antoinette
    Brodsky, Robert A.
    Weitz, Ilene C.
    [J]. HEMATOLOGY, 2020, 25 (01) : 327 - 334
  • [8] Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population
    Wendy Y. Cheng
    Sujata P. Sarda
    Nikita Mody-Patel
    Sangeeta Krishnan
    Mihran Yenikomshian
    Malena Mahendran
    Dominique Lejeune
    Louise H. Yu
    Mei Sheng Duh
    [J]. Advances in Therapy, 2021, 38 : 4461 - 4479
  • [9] Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population
    Cheng, Wendy Y.
    Sarda, Sujata P.
    Mody-Patel, Nikita
    Krishnan, Sangeeta
    Yenikomshian, Mihran
    Mahendran, Malena
    Lejeune, Dominique
    Yu, Louise H.
    Duh, Mei Sheng
    [J]. ADVANCES IN THERAPY, 2021, 38 (08) : 4461 - 4479
  • [10] Antiphospholipid antibodies in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab
    Helley, D.
    Darnige, L.
    de Latour, R. P.
    Zemori, L.
    Socie, G.
    Fischer, A-M
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 624 - 624